BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:43 PM
 | 
Apr 02, 2007
 |  BC Extra  |  Top Story

THRX, GSK meet asthma endpoints

Theravance (THRX) and partner GlaxoSmithKline (LSE:GSK; GSK) reported positive data from a pair of Phase IIb studies of long-acting adrenergic receptor beta 2 agonists (LABAs) to...

Read the full 121 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >